This study is currently not recruiting participants.

Multicenter open-label single dose study to evaluate safety tolerability and pharmacokinetics of LCZ696 followed by a 52-week randomized double-blind parallel group active-controlled study to evaluate the efficacy and safety of LCZ696 compared with enalapril in pediatric patients from 1 month to

Study on the Safety and Effects of an Investigational Medication in Children with Heart Failure

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to find out if the drug LCZ696 is safe and has beneficial effects in children with heart failure who are 1 month to less than 18 years old.

Detailed description of study

The purpose of this study is to find out if the drug LCZ696 is safe and has beneficial effects in children with heart failure who are 1 month to less than 18 years old.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: heart failure
  • Age: 100 years or below
  • Gender: All

This study investigates the safety and effects of an investigational medication in children with heart failure. Heart failure is a condition where the heart does not pump blood as well as it should. The study aims to understand how this medication works in children aged 1 month to less than 18 years.

Participants in the study will undergo various procedures to monitor the effects of the investigational medication. These procedures will help researchers determine if the medication is safe and effective for treating heart failure in children.

  • Who can participate: Children aged 1 month to less than 18 years with heart failure may be eligible to participate.
  • Study details: Participants will receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine.
Updated on 19 Feb 2024. Study ID: 1603355342

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team